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ABSTRACT It has been postulated that some children with recurrent cough but no wheeze have a mild
form of asthma (cough variant asthma), with similar risk factors and an increased risk of future wheeze.
This longitudinal study compared risk factors for isolated night cough and for wheeze in the Leicester
Respiratory Cohort in children aged 1, 4, 6 and 9 years and compared prognosis of children with isolated
night cough, children with wheeze and asymptomatic children.
We included 4101 children aged 1 year, 2854 aged 4 years, 2369 aged 6 years and 1688 aged 9 years. The
prevalence of isolated night cough was 10% at age 1 year and 18% in older children. Prevalence of wheeze
decreased from 35% at 1 year to 13% at 9 years. Although several risk factors were similar for cough and
wheeze, day care, reflux and family history of bronchitis were more strongly associated with cough,
and male sex and family history of asthma with wheeze. Over one-third of preschool children with cough
continued to cough at school age, but their risk of developing wheeze was similar to that of children who
were asymptomatic at earlier surveys. Wheeze tracked more strongly throughout childhood than cough.
In conclusion, our study showed that only some risk factors for cough and wheeze were shared but
many were not, and there was little evidence for an increased risk of future wheeze in children with
isolated night cough. This provides little support for the hypothesis that recurrent cough without wheeze
may indicate a variant form of asthma.
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Children with isolated night cough do not have an increased risk of future wheeze, and risk
factors for cough and wheeze only partially overlap. https://bit.ly/31IbXSC
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Introduction
Cough is common among children, accounts for many consultations and affects quality of life [1]. Most
commonly caused by upper or lower respiratory tract infections, cough is usually self-limiting. However,
some children cough frequently, also apart from infections [2, 3]. Many suffer from asthma and also report
wheeze and shortness of breath. Other children have isolated frequent cough alone, without wheeze or
dyspnoea [4, 5]. It has been suggested that prolonged dry cough is a risk factor for asthma [6]. Some authors
have gone further and postulated the existence of a specific asthma phenotype, called cough variant asthma
(CVA) [7–9]. CVA has been described as a mild variant of asthma, where children present with cough as the
sole symptom, instead of all three key symptoms of cough, wheeze and dyspnoea [10]. The following features
have been described as typical for CVA: a family or personal history of atopy, eosinophilic inflammation,
increased bronchial reactivity including positive exercise tests, a positive response to bronchodilators and an
increased risk for developing wheeze or typical asthma later [9, 11–14].
The existence of CVA as a disease entity has been disputed and many maintain that isolated cough is a
poor marker for asthma and should not be treated as such [8, 15–17]. The epidemiology of isolated cough,
usually defined as night cough without colds, in children is not well studied. Previous publications
included nonsystematic reviews [9, 18], small clinical studies with fewer than 50 patients [12, 19] or
studies on adults [20, 21]. Studies that compare children with isolated cough to children with wheeze and
to asymptomatic children from the same population are scarce [16, 22, 23]. Drawing on the dataset from
the 1998 Leicester Respiratory Cohort (LRC), we compared risk factors for isolated night cough and for
wheeze, and we compared prognosis of children with isolated night cough, children with wheeze and those
with neither symptom. This allowed us to investigate some of the proposed key features of CVA: risk
factors typical for asthma, in particular a personal and family history of atopy and long-term prognosis
(i.e. whether children with isolated night cough are at an increased risk for developing wheeze compared
to asymptomatic children).
Materials and methods
Study design and population
We analysed data from a large, prospective population-based cohort, the LRC [24], which includes a large
proportion of children of South Asian ethnic origin [25–27]. Perinatal and growth data were collected from
birth records and health visitor records. The postal questionnaires collected information on cough, wheeze
and environmental exposures from parents when children were aged 1 year (in 1998) and thereafter at the
children’s ages of 4 years (in 2001), 6 years (in 2003) and 9 years (in 2006). This study includes all LRC
children who were born between May 1996 and April 1997 and who completed the baseline questionnaire in
1998 (n=4101). Among these, 2854 (70%) returned the questionnaire at age 4 years (in 2001), 2369 (58%) at
age 6 years (in 2003) and 1688 (41%) at age 9 years (in 2006). The Leicestershire Health Authority Research
Ethics Committee approved the study (approval nos. 1132, 5005 and 4867).
Current wheeze and night cough
We analysed replies to questions from the ISAAC key questionnaire [28], namely “In the last 12 months,
has your child had a dry cough at night, apart from a cough associated with a cold or a chest infection?”
and “Has your child had wheezing or whistling in the chest in the last 12 months?” We also asked each
time: “In the last 12 months, did the following things cause your child to cough?” with answer categories
including exercise (playing, running), laughing or crying, house dust, pollen (grass, hay, trees, flowers),
contact with pets or other animals and food or drinks.
At each survey, we distinguished three mutually exclusive groups of children based on their symptoms
during the previous 12 months: children with night cough but no wheeze (defined as isolated night cough),
children with wheeze with or without cough and asymptomatic children with neither cough nor wheeze.
Risk factors
We compiled a list of potential risk factors for cough and wheeze from the literature [16, 22, 29],
including demographic factors (sex, ethnicity), parental history of asthma, bronchitis, hay fever and
eczema, exposure to infections (household crowding, day care attendance, older siblings), environmental
exposures (cooking with gas, tobacco smoke exposure, pet ownership), socioeconomic factors (maternal
education, Townsend deprivation index [30]) and perinatal/ early life factors (gestational age, birth weight,
maternal age, breastfeeding, reflux in infancy). We also considered parent-reported clinical factors/
comorbidities, namely atopic diseases (rhinitis, hay fever, eczema) and ear, nose and throat (ENT)
problems (frequent colds, snoring, otitis), as potential predictors of wheeze and cough at the next survey.
Attendance at day care, reflux, ethnicity, family history, older siblings and perinatal and early life factors
were only assessed at age 1 year in 1998.
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Statistical analyses
We calculated the prevalence of isolated night cough and wheeze at ages 1, 4, 6 and 9 years, and then
investigated risk factors for isolated night cough and wheeze at each age using multinomial logistic regression.
We calculated univariable relative risk ratios (RRRs) with 95% confidence intervals (CIs) for isolated night
cough and for wheeze compared to the reference category of asymptomatic children. In adjusted models, we
included all risk factors that were associated with either cough or wheeze in the univariable model (p<0.1).
We used Wald tests to compare whether RRRs differed between cough and wheeze.
We then investigated the prognosis of children with isolated night cough, wheeze and no symptoms by
calculating the proportion of children who had the same phenotype at the next survey and the proportion
who transitioned to another phenotype. We did this for the three different periods from ages 1 to 4 years,
4 to 6 years and 6 to 9 years. We used an overall Chi-squared test of independence between symptoms at
baseline and symptoms at follow-up to assess whether prognosis differed between children with isolated
night cough, children with wheeze and children with none of the symptoms, followed by a subgroup
analysis to test whether children with isolated night cough had a higher risk of developing wheeze than
asymptomatic children using Fisher’s exact test.
Finally, we assessed potential predictors of prognosis (i.e. persistence of isolated night cough or incidence
of wheeze 2–3 years later), in children with cough at baseline. Our main analysis included only children
with isolated night cough at baseline and investigated potential predictors for isolated night cough and for
wheeze at the next survey. In addition to environmental risk factors, we also investigated whether
comorbidities at baseline (atopic diseases and ENT symptoms) predict outcome at the next survey [31].
The layout of our study is shown in figure 1. In a sensitivity analysis we included both children with
isolated night cough and asymptomatic children in the analysis and fitted a multivariable logistic
regression with wheeze at the next survey as the dependent variable and isolated night cough at baseline as
an additional independent variable. Variables associated (p<0.1) with the outcome in the univariable
model were included in the multivariable model. We then applied backward selection to eliminate
variables with p>0.1 from the final model.
Further sensitivity analyses evaluated the robustness of our results. While the main analysis included all
children, who participated in the baseline survey at the age of 1 year and one or more of the following
surveys at 4, 6 or 9 years, the sensitivity analysis included only children who participated in all four
surveys (1318 children, 32% of 4101). Results from this sensitivity analysis were similar to the main
Wheeze
age 1 year
Wheeze
age 4 years
Wheeze
age 6 years
Wheeze
age 9 years
Cough
age 1 year
Cough
age 4 years
Cough
age 6 years
Cough
age 9 years
Asymptomatic
age 1 year
Asymptomatic
age 4 years
Asymptomatic
age 6 years
Asymptomatic
age 9 years
a) Factors tested
for association with
prevalence of
cough and wheeze:
• Sociodemographic
• Family history
• Environmental
• Perinatal
b) Factors tested
for association
with presistence
of cough:
All in (a) + clinical
presentation at
the previous
survey
•
FIGURE 1 Study design: prevalence of wheeze and isolated cough at ages 1, 4, 6 and 9 years, and factors associated with prevalence and
prognosis of these symptoms. The size of rectangular boxes represents the respective number of children with cough, wheeze or no symptoms,
and the width of the arrows semi-quantitatively demonstrates the likelihood to stay in the same or change to a different group at subsequent
surveys.
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analysis (available from the authors). We prepared and analysed the data using Stata 14.0 (Stata
Corporation LP, Austin, TX, USA) and created the figures using R version 3.1.1 (Free Software
Foundation, Boston, MA, USA).
Results
Among the 4101 participants of the 1998 survey, 3300 (80%) were white British and 801 (20%) were of
South Asian ethnic origin (table 1). At the age of 1 year, 35% of parents reported that their child wheezed
(with or without night cough), 23% reported night cough, including 10% with isolated night cough
(without wheeze). Prevalence of isolated night cough increased from 10% in 1-year-olds to 18% in 4-, 6-
and 9-year-olds (table S1). Prevalence of wheeze declined from 35% in 1-year-olds to 17%, 14%, and 13%
respectively in children aged 4, 6 and 9 years.
Risk factors for prevalent cough and wheeze
Some risk factors were shared between children with isolated night cough and wheeze, but many differed
and risk factors changed with age. Results are shown in table 2 for children aged 1 year and tables S2–S4
TABLE 1 Characteristics of the study population at the age of 1 year, in 1998 (n=4101)
n %
Demographic factors
Ethnicity: South Asian 801 20
White 3300 80
Sex: boys 2135 52
Girls 1966 48
Family history#
Asthma 1294 32
Bronchitis 739 18
Hay fever 1846 45
Eczema 1339 33
Indoor exposures
Day care 1030 25
Older siblings 2276 56
Cooking with gas 3051 74
Mother smoking 895 22
Father smoking 1041 25
Any pets 1664 41
Socioeconomic factors
Low maternal education¶ 1956 48
Deprived (Townsend score ⩾1.86)+ 1303 32
Perinatal and early life data
Preterm (gestational age <37 weeks) 281 7
Low birth weight (<2500 g) 293 7
Young mother (<25 years)§ 929 23
Child breastfed 2432 59
Reflux (posseting) in infancy 3061 75
Respiratory problems in the past year
Any night cough 938 23
Any wheeze 1420 35
Isolated night cough 427 10
Cough triggered by: exercise 408 10
aeroallergens 77 2
laughterƒ 727 22
food 427 10
Rhinitis 1291 32
Eczemaƒ 1155 36
Frequent colds (>6 episodes) 777 19
Snoring 2236 55
Otitis 1706 42
#: Either mother or father with a history of the disease; ¶: age at the end of education of mother is
⩽16 years; +: Townsend deprivation index (deprived, the highest two quintiles): deprived (1.86, 5.15), more
deprived (5.16, 11.07); §: when the child was born; ƒ: asked only in part of the cohort. Hay fever was not
inquired about in the 1998 survey.
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for children aged 4, 6 and 9 years. The tables report RRRs for children with cough and children with
wheeze compared to asymptomatic children and similarity p-values, which indicate the difference in
strength of association with risk factors between cough and wheeze. Figures 2–4 and figure S1 summarise
the same results graphically.
Factors that were equally important for both isolated night cough and wheeze were parental history of
bronchitis, low socioeconomic status, exposure to smoking and reflux (posseting or vomiting, age 1 year).
Factors that were associated mainly with isolated night cough were South Asian ethnicity, day care
attendance (age 1 year), paternal smoking and use of gas for cooking (age 4 years). Several factors were
more important for wheeze. Boys had a higher risk for wheeze at all ages, but a lower risk for cough at
ages 6 and 9 years. A family history of asthma or hay fever was associated with wheeze only. Maternal
smoking and presence of older siblings were more strongly associated with wheeze at age 1 year. Low
birthweight, preterm birth and lack of breastfeeding were associated mainly with wheeze. Similarity
p-values suggested that associations differed significantly between wheeze and cough for sex and family
history of asthma at all ages; ethnicity, day care attendance and older siblings at age 1 year; and cooking
with gas, exposure to smoking, low socioeconomic status and preterm birth at age 4 years (table 2 and
tables S2–S4).
Prognosis of isolated night cough and wheeze
Prognosis differed between children with wheeze, those with isolated night cough and those who had no
such symptoms for all intervals studied from ages 1 to 4 years, 4 to 6 years and 6 to 9 years (overall
p-values <0.001, figure 5 and table S5). The proportion of children with isolated night cough, whose cough
TABLE 2 Risk factors for prevalence of isolated night cough and wheeze in 1-year-old children (n=4101). Association of
different factors with cough and wheeze, compared to asymptomatic children, in an unadjusted and adjusted model presented
as relative risk ratio estimates with confidence intervals. Cough was defined as night cough without wheeze.
Risk factors at age 1 year Unadjusted model Adjusted model#
Night cough¶ Wheeze Similarity Night cough¶ Wheeze Similarity
RRR (95% CI) RRR (95% CI) p-value+ RRR (95% CI) RRR (95% CI) p-value+
Demographic data
South Asian ethnicity 1.3 (1.0–1.6) 0.6 (0.5–0.8) <0.001 1.4 (1.0–2.0) 0.8 (0.6–1.0) 0.001
Male sex 0.9 (0.7–1.1) 1.3 (1.1–1.5) 0.003 0.9 (0.7–1.2) 1.3 (1.2–1.6) 0.003
Family history of§
Asthma 1.0 (0.8–1.3) 2.1 (1.8–2.4) <0.001 0.9 (0.7–1.2) 1.7 (1.5–2.0) <0.001
Bronchitis 1.4 (1.0–1.8) 2.0 (1.7–2.3) 0.008 1.4 (1.0–1.9) 1.6 (1.3–2.0) 0.380
Hay fever 1.2 (1.0–1.4) 1.5 (1.3–1.7) 0.049 1.1 (0.9–1.4) 1.2 (1.1–1.4) 0.407
Eczema 1.1 (0.8–1.3) 1.3 (1.1–1.5) 0.109 1.0 (0.8–1.3) 1.0 (0.8–1.1) 0.702
Exposure to infections
Crowding 1.1 (0.9–1.4) 1.2 (1.1–1.4) 0.322 1.1 (0.8–1.4) 1.1 (0.9–1.3) 0.961
Day care 1.6 (1.3–2.0) 1.1 (1.0–1.3) 0.002 1.9 (1.5–2.4) 1.3 (1.1–1.6) 0.008
Older siblings 0.9 (0.7–1.1) 1.2 (1.0–1.4) 0.019 0.9 (0.7–1.2) 1.3 (1.1–1.6) 0.008
Indoor exposures
Cooking with gas 1.2 (0.9–1.5) 1.1 (0.9–1.2) 0.424
Mother smoking 1.1 (0.8–1.4) 1.8 (1.6–2.2) <0.001 1.1 (0.8–1.5) 1.4 (1.2–1.7) 0.104
Father smoking 1.0 (0.8–1.3) 1.3 (1.1–1.5) 0.112 1.0 (0.8–1.4) 1.1 (0.9–1.3) 0.775
Pets 0.8 (0.7–1.0) 1.1 (1.0–1.3) 0.006 0.9 (0.7–1.2) 1.1 (0.9–1.2) 0.273
Socioeconomic factors
Low maternal educationƒ 1.0 (0.8–1.3) 1.3 (1.1–1.4) 0.056 1.1 (0.9–1.4) 1.0 (0.9–1.2) 0.613
Deprivation (Townsend) 1.4 (1.1–1.7) 1.4 (1.2–1.6) 0.908 1.4 (1.0–1.8) 1.5 (1.3–1.8) 0.546
Perinatal and early life
Preterm (GA<37 weeks) 0.8 (0.5–1.3) 1.2 (0.9–1.6) 0.096
Low birthweight (<2500 g) 0.8 (0.5–1.3) 1.1 (0.9–1.5) 0.187
Young mother (<25 yrs)## 1.2 (0.9–1.5) 1.5 (1.3–1.8) 0.048 1.1 (0.8–1.5) 1.4 (1.2–1.7) 0.091
Breastfeeding 1.0 (0.8–1.2) 0.7 (0.6–0.8) 0.021 0.9 (0.7–1.2) 0.9 (0.7–1.0) 0.485
Reflux in infancy 1.7 (1.3–2.2) 1.4 (1.2–1.7) 0.193 1.7 (1.3–2.3) 1.4 (1.2–1.7) 0.163
RRR: relative risk ratio; GA: gestational age. #: Adjusted model includes all covariates with p-values <0.1 for either cough or wheeze in
univariable models; baseline for multinomial regression: asymptomatic children; ¶: defined as night cough without wheeze (ISAAC questions);
+: p-value from test for difference between associations of risk factors with cough and those with wheeze (Wald test); §: parental history
(mother or father); ƒ: end of education of mother at age ⩽16 years; ##: when the child was born.
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persisted, increased from 32% (99 of 305) between age 1 and 4 years, to 42% (160 of 381) from age 4 to 6
years and 39% (97 of 249) from age 6 to 9 years. Wheeze was more persistent than isolated night cough.
Among children with wheeze at age 1 year, 31% (283 of 921) wheezed at age 4 years. Among 4-year-olds
with wheeze, 48% (151 of 315) wheezed again at age 6 years and among 6-year-olds with wheeze, 59% (98
of 165) reported wheeze at age 9 years.
The risk of developing new (incident) wheeze at the next survey was not higher in children with isolated
night cough than in asymptomatic children, with the exception of infants, among whom 17% of those
with isolated night cough reported wheeze 3 years later compared to 9% of asymptomatic children
(p<0.001). In children aged 4 or 6 years, we found no evidence that the risk of wheeze at the next survey
differed between children with isolated night cough and asymptomatic children (p-values 0.133 and 0.071
respectively). The sensitivity analysis (the multivariable regression based on data from both asymptomatic
children and children with isolated night cough; table S6) yielded comparable results. Isolated night cough
was associated with future wheeze in 1-year-olds (OR 2.2 (95% CI 1.5–3.1)), but not in 4-year-olds (1.2
(0.7–2.1)) or 6-year olds (1.4 (0.8–2.5)). The associations with the other risk factors in the multivariable
model were largely comparable to the univariable analysis from table 3; in particular incident wheeze was
associated with male sex in all age groups and with day care and maternal smoking at age 1 year, a high
Townsend score at age 1 year, cooking with gas and low maternal education at age 6 years and rhinitis
and snoring at age 6 years.
Predictors of future symptoms in children with cough
Factors associated with prognosis in children with isolated night cough are shown in table 3. Some factors
were associated with both persistence of isolated night cough and development of wheeze, but more
strongly with wheeze. These included cough triggered by laughter (4 to 6 years) or by aeroallergens (6 to 9
years) and hay fever (6 to 9 years). Persistence of isolated night cough was not strongly associated with
South Asian
Cough
Wheeze
Male sex
Family history of asthma
Bronchitis
Hay fever
Eczema
Crowding
Day care
Cooking gas
Mother smoking
Father smoking
Low maternal education
Deprivation (Townsend)
Low birthweight
Young mother
Breastfeeding
Reflux in infancy
0 1 2 3 4
Relative risk ratio
FIGURE 2 Risk factors for prevalent isolated night cough and wheeze at age 4 years (n=2854). Association of
different factors with cough and with wheeze, compared to asymptomatic children, in a fully adjusted model
(adjusted for all covariates with p-values <0.1 for either cough or wheeze in univariable models), presented as
relative risk ratio estimates with confidence intervals. Cough was defined as night cough without wheeze.
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any of the tested environmental or perinatal factors from ages 1 to 4 years, 4 to 6 years or 6 to 9 years
(table 3). Comorbidities were helpful in older children: persistence of isolated night cough from age 4 to
6 years was predicted by rhinitis, cough triggered by laughter/ crying and snoring at age 4 years;
persistence of isolated night cough from age 6 to 9 years was predicted by frequent infections (frequent
colds, otitis) or allergies (hay fever, cough triggered by aeroallergens) at age 6 years.
Some factors were associated with progression from isolated night cough to wheeze, particularly in older
children. Children with isolated night cough who had a family history of asthma had an increased risk of
later wheeze in all age groups. Children whose isolated night cough was triggered by aeroallergens or by
laughter/ crying at age 4 years had an increased risk of wheeze at age 6 years. Children who had also
rhinitis, hay fever, eczema, cough triggered by aeroallergens, snoring or exposure to pets at age 6 years had
an increased risk of incident wheeze at age 9 years (table 3).
Discussion
This large population-based study compared risk factors and prognosis of isolated night cough with wheeze in
different age groups from infancy to school age. It found that some risk factors were shared for cough and
wheeze, whereas surprisingly many differed. A family history of asthma was more closely associated with
wheeze in all age groups. Male sex was only associated with wheeze, perhaps because of the so-called dysanapsis,
causing young boys to have smaller airways relative to lung size than girls [32, 33]. On the other hand, reflux
and day care in infancy and environmental exposures such as gas cookers and parental smoking were more
strongly associated with isolated night cough than with wheeze. Wheeze persisted more than cough, and
persistence was higher in older children. With the possible exception of 1-year-olds, we found no clear evidence
that children with isolated night cough had a higher risk to develop wheeze than asymptomatic children.
Risk factors for cough have been little studied, mainly in clinical settings [1, 34, 35] and rarely in the
general population [16, 22]. A cross-sectional Danish study of 2978 5-year-olds reported male sex, low
0 1 2 3 4
Relative risk ratio
Cough
WheezeSouth Asian
Male sex
Family history of asthma
Bronchitis
Hay fever
Eczema
Crowding
Mother smoking
Low maternal education
Deprivation (Townsend)
Low birthweight
Pre-term
Young mother
Reflux in infancy
FIGURE 3 Risk factors for prevalent isolated night cough and wheeze at age 6 years (n=2369). Association of
different factors with cough and with wheeze, compared to asymptomatic children, in a fully adjusted model
(adjusted for all covariates with p-values <0.1 for either cough or wheeze in univariable models), presented as
relative risk ratio estimates with confidence intervals. Cough was defined as night cough without wheeze.
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gestational age, maternal asthma and housing conditions as risk factors for wheeze, but not for isolated
cough without colds [22]. The Tucson Children’s Respiratory Study of 987 6-year-olds, identified parental
history of bronchitis and passive smoking as risk factors for cough without colds [16]. Passive smoking
and day care attendance were reported as risk factors for isolated night cough by other studies [36–38].
A Finnish study reported that 7 to 12-year-olds with isolated night cough had an intermediate prevalence
of parental asthma and allergies compared to children with wheeze and asymptomatic children and
suggested that this supports the existence of CVA [39]. In contrast, a cross-sectional Australian study of
1165 school children found no differences between children with isolated night cough and asymptomatic
0 1 2 3 4
Relative risk ratio
Cough
WheezeSouth Asian
Male sex
Family history of asthma
Bronchitis
Hay fever
Cooking gas
Father smoking
Pets
Low maternal education
Deprivation (Townsend)
Low birthweight
Pre-term
Young mother
Breastfeeding
FIGURE 4 Risk factors for prevalent isolated night cough and wheeze at age 9 years (n=1688). Association of
different factors with cough and with wheeze, compared to asymptomatic children, in a fully adjusted model
(adjusted for all covariates with p-values <0.1 for either cough or wheeze in univariable models), presented as
relative risk ratio estimates with confidence intervals. Cough was defined as night cough without wheeze.
Symptoms
at age 1 
Follow up at age 4 years Follow up at age 6 years Follow up at age 9 years
Wheeze at follow up
Isolated cough at follow up
Asymptomatic at follow up
Wheeze
Cough
None
Symptoms
at age 4 
Wheeze
Cough
None
Symptoms
at age 6 
Wheeze
Cough
None
0% 10% 20%30%40%50% 60% 70%80% 90%100% 0% 10% 20%30%40%50% 60% 70%80% 90%100% 0% 10% 20%30%40%50% 60% 70%80% 90%100%
FIGURE 5 Prognosis and tracking of respiratory symptoms in children. Proportion of children with wheeze, isolated night cough or none of the
symptoms, who have wheeze, cough or are asymptomatic 2–3 years later. This figure shows prognosis for three different development periods in
childhood (1 to 4 years, 4 to 6 years and 6 to 9 years).
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TABLE 3 Predictors of future symptoms in children with isolated night cough at baseline for different age intervals (from age 1 to 4 years, from age 4 to 6 years and
from age 6 to 9 years). Example for the youngest age group: in children with isolated night cough at age 1 year, what are the factors associated with persistence of
isolated night cough versus incidence of wheeze at age 4 years? The presented associations are univariable.
Risk factors at baseline From age 1 to 4 years (n=305) From age 4 to 6 years (n=381) From age 6 to 9 years (n=249)
Night cough# Wheeze Similarity Night cough# Wheeze Similarity Night cough# Wheeze Similarity
RRR (95% CI) RRR (95% CI) p-value¶ RRR (95% CI) RRR (95% CI) p-value¶ RRR (95% CI) RRR (95% CI) p-value¶
South Asian ethnicity 1.0 (0.5–1.8) 1.3 (0.6–2.7) 0.412 1.2 (0.7–2.2) 1.8 (0.7–4.5) 0.380 1.1 (0.5–2.2) 0.7 (0.2–2.5) 0.486
Male sex 0.8 (0.5–1.3) 1.6 (0.9–3.1) 0.037 0.7 (0.5–1.1) 1.7 (0.8–3.7) 0.029 0.8 (0.5–1.4) 2.2 (0.9–5.6) 0.036
Family history of
Asthma 1.2 (0.7–2.3) 3.0 (1.5–6.0) 0.018 1.3 (0.8–2.0) 2.3 (1.1–5.0) 0.127 1.0 (0.5–1.8) 3.4 (1.4–8.2) 0.009
Bronchitis 0.7 (0.4–1.4) 1.4 (0.7–3.0) 0.112 1.1 (0.6–1.9) 1.1 (0.4–2.8) 0.988 1.5 (0.7–2.9) 1.8 (0.6–5.0) 0.724
Hay fever 0.9 (0.6–1.5) 1.3 (0.7–2.5) 0.288 1.3 (0.8–1.9) 1.8 (0.9–3.9) 0.350 1.7 (1.0–2.9) 1.6 (0.7–3.8) 0.895
Eczema 1.2 (0.7–2.0) 1.0 (0.5–1.9) 0.598 1.4 (0.9–2.2) 1.8 (0.8–4.0) 0.472 0.6 (0.3–1.0) 0.8 (0.3–1.9) 0.538
Exposure to infections
Crowding 1.0 (0.6–1.8) 1.4 (0.7–2.7) 0.425 0.9 (0.5–1.4) 1.5 (0.7–3.4) 0.179 1.1 (0.6–1.8) 1.1 (0.4–2.7) 0.953
Day care at age 1 year 1.2 (0.6–2.3) 0.3 (0.1–0.7) 0.003
Older siblings 0.8 (0.5–1.4) 0.6 (0.3–1.1) 0.315 1.0 (0.6–1.5) 0.7 (0.3–1.6) 0.530 1.2 (0.7–2.1) 1.5 (0.6–3.7) 0.654
Air pollution
Cooking with gas 1.1 (0.6–1.9) 0.7 (0.4–1.5) 0.352 1.3 (0.7–2.2) 1.4 (0.5–3.8) 0.883 1.3 (0.7–2.4) 3.1 (0.9–11.0) 0.207
Mother smoking 1.3 (0.7–2.7) 2.2 (1.0–4.8) 0.214 1.3 (0.7–2.4) 0.7 (0.2–2.4) 0.289 1.0 (0.5–2.0) 1.0 (0.3–3.1) 0.984
Father smoking 1.2 (0.7–2.2) 1.1 (0.5–2.3) 0.788 1.0 (0.6–1.6) 0.7 (0.3–1.9) 0.529 1.0 (0.5–2.0) 0.9 (0.3–2.7) 0.814
Allergens
Pets 1.0 (0.6–1.7) 0.6 (0.3–1.2) 0.171 1.0 (0.7–1.5) 0.6 (0.3–1.3) 0.188 0.9 (0.6–1.6) 2.5 (1.0–6.0) 0.043
Socioeconomic factors
Low maternal education+ 1.0 (0.6–1.6) 1.1 (0.6–2.0) 0.802 1.0 (0.6–1.5) 0.6 (0.3–1.3) 0.233 1.6 (1.0–2.8) 2.2 (0.9–5.2) 0.552
Deprivation (Townsend) 0.7 (0.4–1.3) 1.7 (0.9–3.2) 0.019 1.4 (0.9–2.3) 2.1 (0.9–4.6) 0.338 1.1 (0.6–1.9) 0.4 (0.1–1.3) 0.095
Perinatal and early life
Preterm (GA<37 weeks) 0.3 (0.03–2.2) 1.5 (0.4–6.4) 0.125 1.0 (0.4–2.5) 2.5 (0.7–8.6) 0.130
Low birthweight (<2500 g) 3.3 (0.8–13.5) 2.0 (0.3–12.6) 0.566 1.0 (0.4–2.4) 1.7 (0.4–6.3) 0.440
Young mother (<25 years) 1.2 (0.6–2.2) 1.3 (0.6–2.9) 0.753 1.3 (0.8–2.3) 1.3 (0.5–3.3) 0.922 1.2 (0.6–2.5) 1.6 (0.5–4.8) 0.616
Breastfeeding 0.8 (0.5–1.3) 0.7 (0.3–1.3) 0.694 1.1 (0.7–1.7) 0.6 (0.3–1.4) 0.191 0.5 (0.3–0.9) 0.4 (0.2–1.1) 0.683
Reflux in infancy 1.4 (0.7–2.7) 1.5 (0.6–3.4) 0.920 0.9 (0.6–1.5) 1.9 (0.6–5.7) 0.206 0.9 (0.5–1.8) 0.6 (0.2–1.6) 0.370
Clinical factors
Rhinitis 1.2 (0.7–2.0) 1.0 (0.5–2.0) 0.640 1.6 (1.0–2.5) 1.9 (0.9–4.1) 0.655 1.3 (0.8–2.3) 3.5 (1.4–8.7) 0.042
Hay fever§ 1.1 (0.5–2.0) 1.9 (0.7–2.3) 0.270 4.3 (1.6–11.4) 5.3 (1.5–19.1) 0.722
Current eczema 1.0 (0.5–1.9) 1.5 (0.7–3.1) 0.335 1.3 (0.6–1.9) 2.1 (0.8–5.3) 0.175 1.6 (0.9–3.0) 3.4 (1.4–8.4) 0.110
Cough triggered by: exercise 1.1 (0.5–2.7) 3.8 (1.7–8.8) 0.010 1.3 (0.8–2.1) 1.9 (0.8–4.2) 0.409 1.4 (0.7–2.5) 4.1 (0.5–10.9) 0.034
aeroallergens 0.3 (0.03–2.7) 1.9 (0.4–8.0) 0.123 1.4 (0.7–2.8) 3.0 (1.1–8.0) 0.113 5.2 (2.0–13.6) 8.3 (2.5–27.6) 0.370
laughter 2.3 (1.2–4.4) 1.2 (0.5–2.8) 0.138 1.7 (1.0–2.8) 4.1 (1.5–11) 0.071 1.7 (0.9–3.3) 1.0 (0.3–3.0) 0.343
food 1.3 (0.7–2.6) 0.7 (0.2–1.8) 0.187 1.0 (0.5–1.9) 1.0 (0.3–3.6) 0.953 1.9 (0.8–4.6) 0.5 (0.1–4.5) 0.237
Frequent coldsƒ 0.8 (0.4–1.4) 0.9 (0.4–2.0) 0.640 1.1 (0.5–2.3) 1.0 (0.3–3.8) 0.906 4.8 (1.3–17.8) 1.8 (0.2–18.0) 0.366
Snoring 0.8 (0.5–1.4) 2.1 (1.0–4.4) 0.020 1.9 (1.1–3.0) 2.1 (0.9–5.2) 0.777 1.3 (0.7–2.3) 3.4 (1.1–10.6) 0.105
Otitis at least once 1.1 (0.7–1.9) 0.9 (0.5–1.7) 0.437 1.0 (0.7–1.6) 1.4 (0.7–3.0) 0.408 2.1 (1.2–3.7) 1.6 (0.6–3.9) 0.546
RRR: relative risk ratio; GA: gestational age. #: Cough defined as night cough and no wheeze; ¶: p-value from test for difference between associations of risk factors with cough and
those with wheeze (Wald test); +: end of education of mother at age ⩽16 years; §: not inquired about in 1998 survey; ƒ: >6 episodes of colds in the past year.
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children with respect to family history of asthma, parental smoking and atopic status, and concluded that
children with isolated persistent cough without colds are unlikely to have asthma [15]. In our study we
identified risk factors that were similar for cough and wheeze, such as family history of bronchitis and
reflux, and others that differed (including ethnicity, sex, family history of asthma and day care attendance).
Prognosis of isolated night cough in children has received little attention in previous studies. Figure 1
shows that both cough and wheeze tracked more strongly with increasing age and that wheeze tracked
more than cough. But we found no evidence that the risk of later wheeze was higher for children with
isolated night cough than for asymptomatic children. In the first LRC (482 children born between 1985
and 1990, with no overlap with our study population), 37% of 3-year-olds with cough continued to cough
at age 6 years and 7% developed wheeze [40]. This is similar to what we found from age 4 to 6 years in
the second LRC: 42% continued coughing and 8% developed wheeze. Some studies investigated whether
children with night cough progress to wheeze/ asthma, but did not assess persistence of cough [41, 42].
Among the 3252 children of the Prevention and Incidence of Asthma and Mite Allergy birth cohort, fewer
than 10% of children with isolated night cough at age 2–7 years developed asthma at age 8 years and this
was comparable to asymptomatic children [41]. The Tucson Children’s Respiratory Cohort found that
cough without colds at age 2 years persisted in 40% of children by age 6 years and in 35% from age 6–11
years. Risk factors for cough persistence were parental smoking from age 2–6 years and atopy from age
6–11 years [16]. We found that school children with isolated night cough had an increased risk for future
wheeze if they also suffered from rhinitis, hay fever or cough triggered by typical asthma triggers. Overall,
though, children with isolated night cough did not have a substantially higher risk of developing wheeze
than asymptomatic peers.
Our study has several strengths. It is the first to compare risk factors and prognosis among children with
isolated night cough and children with wheeze in a large cohort from the general population. It employed
consistent methodology with standardised questions to assess symptoms and environmental factors in four
surveys. It is also the first study to have investigated factors that predict persistence of isolated night cough
and incidence of wheeze. Our cohort included a large proportion (20%) of children of South Asian ethnic
origin. South Asian ethnicity was a risk factor for cough, particularly in 1-year-olds, but not wheeze. The
reason for this remains unclear, but could include the fact that South Asian children in the United
Kingdom are more often atopic than white children, are more commonly exposed to indoor air pollution
from cooking or heating and are in average more deprived [25]. Although we adjusted for all this, there
may be residual confounding. Also, understanding of the word “wheeze” is poorer among parents from
this ethnic group [43].
The study has also limitations. The main is its dependence on parental reports. Cough is more easily
overheard by parents than wheeze, particularly at night. This might have affected prevalence estimates of
night cough compared to wheeze, but should not have biased associations with risk factors or comparison
of prognosis between groups. Similarly, lower response rates in later surveys might have affected prevalence
of symptoms, but not association with risk factors or comparisons of prognosis. The fact that results were
comparable between the main analysis that included all children who participated at least once, and the
sensitivity analysis that focused on those who participated in all four surveys, is reassuring. Another
limitation of our study is that we do not have data on the duration of night cough (i.e. whether this
problem persisted for longer than 4 weeks). Also, we only studied two characteristics of CVA, as we could
not assess physiological traits of CVA in this questionnaire-based study, namely eosinophilic inflammation,
bronchial hyperreactivity and response to bronchodilators.
Overall, the results of our study contradict reports suggesting that children with recurrent dry cough have a
variant form of asthma or risk to develop asthma in the future. Many of the earlier positive studies had
methodological weaknesses, such as lack of comparison groups, small selective study populations [12, 19] or
were conducted in adults [20, 21]. The few that compared children with cough to children with wheeze
and asymptomatic children in the same population found, as we did, little evidence for the existence of CVA
[16, 22, 23].
A number of alternative causes of chronic dry cough in children have been described. These include
neuronal mechanisms and cough receptor hypersensitivity, especially nonspecific post-infectious
hypersensitivity [44, 45]. Children with different neurophenotypes show variable sensitivities to a range of
cough challenge stimuli such as capsaicin [46]. Chronic upper respiratory disease of allergic or nonallergic
origin can cause cough secondary to nocturnal mouth breathing or post-nasal drip with stimulation of
pharyngolaryngeal receptors [47, 48]. Gastroesophageal reflux can cause chronic cough in children
through laryngeal soiling, pulmonary aspiration or vagal reflexes [49]. Chronic wet cough can be a sign of
a more severe disease, such as a protracted bacterial bronchitis and disorders that affect
bronchopulmonary clearance [3].
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In summary, this population-based study found that risk factors for isolated dry night cough differed
substantially from risk factors for wheeze and that children with isolated night cough were not more likely
to develop wheeze in the future than asymptomatic children. Findings were slightly different for
1-year-olds. Perhaps this is due to the general difficulty of diagnosing asthma at this age and because both
cough and wheeze in infants are usually triggered by infections, whereas asthma later in childhood is often
triggered by allergens or exercise. Overall, however, our study provides little support for the hypothesis
that children with chronic dry cough at night have a variant form of asthma.
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